STTR Phase I: Smart IoT Wearable for Remote Monitoring and Assessment of COVID-19 Patients (COVID-19)

这项小企业技术转让（STTR）第一阶段项目的更广泛影响/商业潜力将帮助COVID-19患者减轻医疗系统的负担。该项目将导致低成本的可穿戴物联网（IoT）系统，以实现改进的远程医疗。收集到的数据可用于公共卫生目的。拟议的项目将开发远程医疗软件工具，使用可穿戴设备的实时生理数据，该设备价格合理、舒适、无创、可清洗、可重复使用。该STTR一期项目将为出现干咳、呼吸急促和发烧等COVID-19体征和症状的患者制定风险分层机制。这种类型的下呼吸道疾病可以在家中进行治疗，而不需要住院。我们的目标包括开发：1)用于诊断COVID-19和类似连续疾病的病症的多模态系统；2)软件远程医疗接口，具有学习和评估进一步住院需要的算法；3)试点研究。该奖项反映了美国国家科学基金会的法定使命，并通过使用基金会的知识价值和更广泛的影响审查标准进行评估，被认为值得支持。

The broader impact /commercial potential of this Small Business Technology Transfer (STTR) Phase I project will help COVID-19 patients with a lower burden to the medical system. This project will lead to a low-cost wearable internet of things (IoT) system to enable improved telemedicine. The collected data can be leveraged for public health purposes. The proposed project will develop telemedicine software tools using real-time physiological data from a wearable that is affordable, comfortable, non-invasive, washable, and reusable.This STTR Phase I project will develop a risk stratification mechanism for patients who experience signs and symptoms suggestive of COVID-19 such as dry cough, shortness of breath, and a fever. Such type of lower respiratory tract illness could be managed at home without resorting to hospital admission. Our objectives include development of: 1) a multi-modality system for diagnosing illness conditions for COVID-19 and similar contiguous diseases; 2) a software telemedicine interface with algorithms that learn and assess the need for further hospitalization; 3) a pilot study.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.